Furthermore, it only selects CTCs expressing EpCAM; thus, other CTC phenotypes are missed, such as mesenchymal and stem cell-like tumour cells that have low levels or no EpCAM expression [58,59,60]. This evidence concerns the gene EPCAM and neoplasm.